BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 34379989)

  • 1. Secondary infection in severe and critical COVID-19 patients in China: a multicenter retrospective study.
    Sang L; Xi Y; Lin Z; Pan Y; Song B; Li CA; Zheng X; Zhong M; Jiang L; Pan C; Zhang W; Lv Z; Xia J; Chen N; Wu W; Xu Y; Chen S; Liu D; Liang W; Liu X; Liu X; Li S; Zhong N; Ye D; Xu Y; Zhang N; Zhang D; Li Y
    Ann Palliat Med; 2021 Aug; 10(8):8557-8570. PubMed ID: 34379989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.
    Polly M; de Almeida BL; Lennon RP; Cortês MF; Costa SF; Guimarães T
    Am J Infect Control; 2022 Jan; 50(1):32-38. PubMed ID: 34562526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary infections in a cohort of patients with COVID-19 admitted to an intensive care unit: impact of gram-negative bacterial resistance.
    Costa RLD; Lamas CDC; Simvoulidis LFN; Espanha CA; Moreira LPM; Bonancim RAB; Weber JVLA; Ramos MRF; Silva ECF; Oliveira LP
    Rev Inst Med Trop Sao Paulo; 2022; 64():e6. PubMed ID: 35137900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outbreak within an outbreak: The impact of Infection Prevention and Control strategies on hospital-acquired infections and the occurrence of multi-drug resistant organisms during the COVID-19 pandemic.
    Mashigo B; Parker A; Lalla U; Allwood BW; Moolla MS; Lovelock T; Koegelenberg CFN
    S Afr Med J; 2023 Dec; 113(12):42. PubMed ID: 38525636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
    Li J; Wang J; Yang Y; Cai P; Cao J; Cai X; Zhang Y
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):153. PubMed ID: 32962731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China.
    Jiang AM; Shi X; Liu N; Gao H; Ren MD; Zheng XQ; Fu X; Liang X; Ruan ZP; Yao Y; Tian T
    BMC Infect Dis; 2020 Jun; 20(1):452. PubMed ID: 32600270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.
    Sharifipour E; Shams S; Esmkhani M; Khodadadi J; Fotouhi-Ardakani R; Koohpaei A; Doosti Z; Ej Golzari S
    BMC Infect Dis; 2020 Sep; 20(1):646. PubMed ID: 32873235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital.
    Tian H; Chen L; Wu X; Li F; Ma Y; Cai Y; Song S
    Dig Dis Sci; 2020 Jul; 65(7):2079-2088. PubMed ID: 31691173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings.
    Cultrera R; Barozzi A; Libanore M; Marangoni E; Pora R; Quarta B; Spadaro S; Ragazzi R; Marra A; Segala D; Volta CA
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33923992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 16. The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-centre study.
    Gajic I; Jovicevic M; Popadic V; Trudic A; Kabic J; Kekic D; Ilic A; Klasnja S; Hadnadjev M; Popadic DJ; Andrijevic A; Prokic A; Tomasevic R; Ranin L; Todorovic Z; Zdravkovic M; Opavski N
    J Hosp Infect; 2023 Jul; 137():1-7. PubMed ID: 37121488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.
    Huang H; Chen B; Liu G; Ran J; Lian X; Huang X; Wang N; Huang Z
    BMC Infect Dis; 2018 Jan; 18(1):11. PubMed ID: 29304746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
    Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
    PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19.
    Baiou A; Elbuzidi AA; Bakdach D; Zaqout A; Alarbi KM; Bintaher AA; Ali MMB; Elarabi AM; Ali GAM; Daghfal J; Almaslamani MA; Ibrahim ASS; Alkhal A; Omrani AS
    J Hosp Infect; 2021 Apr; 110():165-171. PubMed ID: 33561503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.